CRISPR-Cas技術:研究から臨床応用までの新興ツール
Hana Hyeon1, Soonhye Hwang1, Yongyang Luo1
1Department of Life Science, Chung-Ang University, Seoul 06974, Republic of Korea.
Journal of microbiology (Seoul, Korea)
|August 29, 2025
まとめ
CRISPR-Cas遺伝子治療のツールは 遺伝疾患の治療に多岐にわたる応用が可能です 投与システムと精密な編集技術の進歩は 将来の治療の治療効率と安全性を高めています
科学分野:
- バイオテクノロジー
- 分子生物学
- 遺伝学
背景:
- CRISPR-Casシステムは 遺伝子治療における革命的なツールです
- 様々なCRISPR- Casプラットフォームが開発されており,その中にはSpCas9の変種と他のCas酵素が含まれています.
- 塩基エディター,プライムエディター,Cas13,CRISPRa/iシステムは,ゲノムとRNAの編集機能を拡張します.
研究 の 目的:
- 様々なCRISPRベースのツールとその配信システムをレビューする.
- 遺伝子治療におけるCRISPR-Cas技術の臨床的進歩と革新的な展望を強調する.
- 遺伝疾患の治療における CRISPR ベースの治療法の可能性を議論する.
主な方法:
- 異なるCas酵素と編集システム (ベースエディター,プライムエディター,Cas13,CRISPRa/i) を含むCRISPR-Cas技術のレビュー
- CRISPR-Casコンポーネント (電解,AAV,脂質ナノ粒子) の様々な配送方法の分析
- 標的型投与技術の臨床進歩と進行中の開発の検討
主要な成果:
- CRISPR-Cas技術は 汎用的な遺伝子編集と遺伝子発現の制御を提供します
- CRISPR-Casのコンポーネントを輸送するには様々な配送方法が用いられます.
- 継続的な進歩は,治療の効率,安全性,安定性を改善することに焦点を当てています.
結論:
- CRISPRベースの治療法は 永久的なゲノム修正を通じて 遺伝疾患の治療に 莫大な可能性を秘めています
- 治療の成果を向上させるには 標的型投与の継続的な開発が不可欠です
- CRISPR技術は 遺伝子治療の将来に 革新的な可能性を秘めています
関連する概念動画
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR/Cas9 Genome Editing
211
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
211
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
Homologous Recombination
51.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
51.5K
The Antiviral System of Bacteria and Archaea: CRISPR
123
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
123


